NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 172

DEA Research and Development Clinical Trials Marijuana 172

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. Junk’ cannabis ‘ill-suited for clinical trials’.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

SEPTEMBER 10, 2021

The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. Clerkenwell Health is a psychedelic specialist clinical research organisation, based in the UK, backed with investment from VC Fund Vine Ventures, and Angel investors.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

SEPTEMBER 22, 2021

Despite this, the Home Office “fails to act, perpetuating what can be considered the worst research blackout in scientific history,” according to the Conservative Drug Policy Reform Group (CDPRG), of which Mr Blunt is chairman. The first part of their review was published in July and the second part of the work is now underway.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

NOVEMBER 19, 2021

“These patent filings are critical components of PsyBio’s corporate development strategy. “These patent filings are critical components of PsyBio’s corporate development strategy. PsyBio remains interested in developing the intellectual property landscape within the psycho-targeted development drug arena.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

AUGUST 10, 2021

Shanti”), and all its assets focused on psychedelic MDMA-based drug development. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. billion in 2030.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

NOVEMBER 15, 2021

a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

FEBRUARY 10, 2022

Controlled research into psilocybin for therapeutic purposes reveals that it may allow people suffering from depression, anxiety, PTSD, and potentially addiction, to more easily face and overcome painful or stressful memories and experiences. Background. Psilocybin. Psilocybin is the hallucinogenic chemical found in “magic mushrooms.”

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JUNE 24, 2022

Scutari’s proposed “Psilocybin Behavioral Health Access and Services Act” represents a bold development in the psychedelics reform movement that’s rapidly spread in state legislatures and through citizen-led initiatives throughout the country in recent years. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

JUNE 20, 2021

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

SEPTEMBER 23, 2022

Going forward, MAPS will focus on advocating for psychedelic policy reform to include state funding for public education, harm reduction, and unarmed crisis response services. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. The new Congress was just sworn in yesterday, and they are not wasting any time.

Legislation 128

Legislation Clinical Trials Research and Development Access 128

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Cannabis Law Report

NOVEMBER 23, 2021

. “If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted,” warn researchers. Patents on Psychedelics: The Next Legal Battlefront of Drug Development. Read more at [link]. Harvard Law Review Forum, Vol. 135, 2022 (Forthcoming).

Law 52

Law Research and Development Therapy Clinical Trials 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. The right candidate will have a passion for clinical research in novel therapeutics to address unmet medical need and a proven track record of success in regulatory affairs.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

MMJ Recs

DECEMBER 17, 2023

Any potential expansion of patient rights would likely depend on future legislative changes and developments in the state’s approach to medical marijuana. Future development may also include: Increased THC Limits: Future changes may involve reconsidering and potentially increasing the THC limits for medical marijuana products.

Law 52

Law Dispensary Clinical Trials Programs 52

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The research we completed is exploratory but the results are consistent with our earlier research. “The We look forward to the next chapters in their development”. Karl Kottmeier” President.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co Source: [link].

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. By contrast, state and local governments are the primary regulators with respect to the creation and enforcement of policies governing to production, use, and sale of alcohol and tobacco. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

United Patients Group

JANUARY 5, 2023

A growing body of research suggests that probiotics can help protect us from illness and disease, improve our mental health, and strengthen our immune system. He adds that research has shown that probiotics can help the immune system produce more antibodies to fight off viruses and bacteria. Introduction.

Digestion 85

Digestion Research and Development Food Strains 85

CannaTech

JANUARY 27, 2019

The Latin American investment opportunities range from scientific research for pharmaceuticals to formulated products for nutraceuticals, and everything that is required in between (e.g. From clinical trials to cosmetics, the region is gearing up for high return and low cost of production. land, labs, licenses).

Clinical Trials 81

Clinical Trials Cultivation Research and Development Cannabis 81

Cannabis Law Report

JUNE 9, 2022

The bill aims to improve the quality of medical services for the population that undergoes palliative medicine and encourage medical research on cannabis. “; 4) Article 11 shall be worded as follows: ” Article 11. .”; “; 4) Article 11 shall be worded as follows: ” Article 11.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

APRIL 10, 2019

These include “to initiate a process evaluation to address barriers” and to ask “the National Institute for Health Research and the industry to take action to produce … evidence in a form that will support decisions about public funding.”. Friend makes an excellent point.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

JUNE 1, 2021

Drake is well-known as an inspiring and inclusive leader who is dedicated to the development of her teams and solely focused on organizational success for the benefit of patients. Company remains on track for potential approval of Vicineum™ in the US in August 2021. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JULY 25, 2022

Conversation Tackles MAPS Research Methadology & Issues Of Abuse In Therapy. Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. ” Underground researcher. . she says.

Medicine 52

Medicine Therapy Research and Development Business 52

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Regardless all these regulatory developments, what did change, in fact?

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

DECEMBER 20, 2021

The three states that presently have a policy on hemp cultivation are Uttarakhand, Uttar Pradesh, and Madhya Pradesh. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules. Recent Development. Cannabis is a Schedule E(1) drug under the Drugs & Cosmetics Rules, 1945 9.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. UK cannabis policy is not serving the interests of patients.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Canna Law Blog

NOVEMBER 6, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Research was permitted in the mid-20th century, until the law stepped in.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

AUGUST 25, 2022

The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. Policy and Advocacy Director, MAPS. Its main focuses include establishing sentencing policies, advising Congress and the executive branch in developing criminal justice policy, and analyzing and distributing information on federal sentencing issues.

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52